← Leaderboards
David Liu
Massachusetts General Hospital
$1,231,304
Attributed
$1,231,304
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $250.8K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,231,304 · 1
By mechanism
K08$1,231,304 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- E. Antonio Chiocca$34,514,665
- Ben Z Stanger$14,778,829
- Nabeel Bardeesy$18,920,034
- Leif W Ellisen$14,503,955
- Xandra Owens Breakefield$30,735,276
Others in their field
Other Emerging Leaders on “Light”
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Susan Abushakra · Alzheon, Inc.$47,265,244
- James Dale Berry · Brigham And Women'S Hospital$25,017,559
- Arnab Kumar Chatterjee · Washington University$22,541,385
- Scott Fry$21,470,000
Research focus
LightAlgorithmsInsightIndividual PatientBiologicalBiological MarkersAutomobile DrivingImmunotherapyBindingClinical DataClinically RelevantClinical MarkersCohortCombined Modality TherapyComputational BiologyBraf GeneClassificationImmune Checkpoint BlockadeClinical BiomarkersEpigenetic ProcessEventFrequenciesGenomicsLongitudinal Analysis
Grant awards (6)
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology$250,795
K08 · FY2022 · CA · contact PI
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology$250,795
K08 · FY2021 · CA · contact PI
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology$250,795
K08 · FY2020 · CA · contact PI
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology$228,089
K08 · FY2019 · CA · contact PI
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology$182,563
K08 · FY2018 · CA · contact PI
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology$68,267
K08 · FY2018 · CA · contact PI